Vero Biosciences

You are only as young as your oldest organ

Employees
1–10
Business Model
B2B
Last Round
Seed
Rounds
1

About

Vero Biosciences is a longevity diagnostics company that uses AI-powered proteomics and machine learning to measure the biological age of individual organs from a single blood draw. Developed on research from Stanford University involving 45,000+ individuals over 15 years, Vero's Proteomic OrganAge platform analyzes 11,000+ proteins with organ-specific signatures to detect accelerated aging years before traditional clinical markers appear. The company's Vero Compass platform integrates biological, clinical, and wearable data to guide precise organ-targeted interventions and extend healthspan.

Summary

Vero Biosciences is an Artificial Intelligence company based in United States. Investors include Khosla Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed Round

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vero Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/vero-biosciences"><img src="https://indexed.vc/api/badge/company/vero-biosciences" alt="Vero Biosciences on Indexed.vc" width="260" height="76" /></a>